Otros idiomas IGC Pharma, Inc.

Acciones

IGC

US45408X3089

Mercado cerrado - Nyse Otros sitios de cotización 22:10:00 24/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,4894 ^USD	-0,12 %		-12,61 %	+74,72 %

16/04	IGC Pharma, Inc anuncia que los datos provisionales de su ensayo clínico de fase 2 demuestran una reducción clínicamente significativa, cercana a la significación estadística, de la agitación en el Alzheimer en la segunda semana en comparación con el placebo	CI
22/03	Aurora y Canopy, entre los valores del cannabis al alza tras la aprobación en Alemania de la ley de legalización parcial	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

IGC Pharma to Attend BIO International Convention 2024	21/05
6.7 Million Americans Live With Alzheimerâ€™s â€“ IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings	09/05
IGC PHARMA : Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation	26/04
IGC-AD1'S Interim Phase 2 Data Show a Reduction in Alzheimer's Agitation at Week Two	17/04
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two	16/04
IGC Pharma, Inc Announces Interim Data from Its Phase 2 Clinical Trial Demonstrates Clinically Significant Reduction, Approaching Statistical Significance, in Agitation in Alzheimer?S At Week Two Compared to Placebo	16/04
IGC Pharma Adds Advisor in Artificial Intelligence	09/04
IGC Pharma : Announces Positive Interim Results for IGC-AD1 in - Form 8-K	05/04
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock	26/03
Aurora, Canopy Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law	22/03
Aurora Cannabis, Canopy Growth Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law	22/03
IGC Pharma : Material Agreement - Form 8-K	22/03
IGC Pharma, Inc. announced that it has received $3 million in funding from Bradbury Asset Management (Hong Kong) Limited	22/03
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer's Agitation	21/03
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation	20/03
IGC Pharma, Inc Announces the Results of an Interim Analysis of its Ongoing Phase 2 Trial Investigating IGC-Ad1 as Treatment for Agitation in Dementia from Alzheimer?s Disease	20/03
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024	20/03
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline	12/03
Igc Pharma, Inc. Appoints Terry Lierman as Independent Director to Its Board of Directors	12/03
Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model	28/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas IGC Pharma, Inc.

Acciones

IGC

US45408X3089

Otros idiomas

Filtros